Keystone Financial Group Abbott Laboratories Transaction History

Keystone Financial Group

$973 Million
Q4 2024

A detailed history of Keystone Financial Group transactions in Abbott Laboratories stock. As of the latest transaction made, Keystone Financial Group holds 36,634 shares of ABT stock, worth $4.84 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

36,634

Previous 16,796 118.11%

Holding current value

$4.84 Million

Previous $1.91 Million 116.46%

% of portfolio

0.43%

Previous 0.65%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$111.93 - $119.39 $2.22 Million - $2.37 Million	19,838 Added 118.11%	36,634 $4.14 Million
Q3 2024 Feb 19, 2025	SELL	$100.07 - $118.13 $1.99 Million - $2.34 Million	-19,838 Reduced 54.15%	16,796 $1.91 Million
Q3 2024 Feb 18, 2025	SELL	$100.07 - $118.13 $1.23 Million - $1.45 Million	-12,242 Reduced 33.42%	24,392 $2.78 Million
Q3 2024 Feb 13, 2025	SELL	$100.07 - $118.13 $1.99 Million - $2.34 Million	-19,838 Reduced 54.15%	16,796 $1.91 Million
Q3 2024 Nov 12, 2024	SELL	$100.07 - $118.13 $22,415 - $26,461	-224 Reduced 1.32%	16,796 $1.91 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $34,550 - $38,566	343 Added 2.06%	17,020 $1.77 Million
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $11,171 - $12,337	-102 Reduced 0.61%	16,677 $1.9 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $137,359 - $168,139	-1,523 Reduced 8.32%	16,779 $1.85 Million
Q3 2023 Nov 06, 2023	SELL	$95.53 - $114.62 $36,779 - $44,128	-385 Reduced 2.06%	18,302 $1.77 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $52,607 - $58,615	-522 Reduced 2.72%	18,687 $2.04 Million
Q4 2022 Feb 07, 2023	SELL	$95.06 - $111.52 $213,504 - $250,473	-2,246 Reduced 10.47%	19,209 $2.11 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $150,752 - $174,542	1,558 Added 7.83%	21,455 $2.08 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $13,269 - $16,038	130 Added 0.66%	19,897 $2.16 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $157,917 - $192,570	1,385 Added 7.53%	19,767 $2.34 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $222,395 - $272,310	-1,925 Reduced 9.48%	18,382 $2.59 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $100,327 - $110,991	-860 Reduced 4.06%	20,307 $2.4 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $54,799 - $64,506	-518 Reduced 2.39%	21,167 $2.45 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $85,004 - $100,147	-781 Reduced 3.48%	21,685 $2.6 Million
Q4 2020 Feb 10, 2021	SELL	$105.0 - $114.42 $3,045 - $3,318	-29 Reduced 0.13%	22,466 $2.46 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $45,820 - $55,645	500 Added 2.27%	22,495 $2.45 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $71,363 - $91,336	932 Added 4.42%	21,995 $2.01 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $66,400 - $97,096	-1,057 Reduced 4.78%	21,063 $1.66 Million
Q4 2019 Feb 06, 2020	SELL	$78.51 - $87.4 $37,920 - $42,214	-483 Reduced 2.14%	22,120 $1.92 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $5,810 - $6,300	-71 Reduced 0.31%	22,603 $1.89 Million
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $12,681 - $14,790	174 Added 0.77%	22,674 $1.91 Million
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $386,592 - $467,390	5,838 Added 35.04%	22,500 $1.8 Million
Q4 2018 Feb 11, 2019	BUY	$65.56 - $74.27 $67,461 - $76,423	1,029 Added 6.58%	16,662 $1.21 Million
Q3 2018 Nov 06, 2018	BUY	$60.81 - $73.36 $306,543 - $369,807	5,041 Added 47.59%	15,633 $1.16 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $39,723 - $43,842	690 Added 6.97%	10,592 $646,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $106,125 - $119,987	1,886 Added 23.53%	9,902 $576,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $430,298 - $460,679	8,016	8,016 $471,000

Others Institutions Holding ABT

# of Institutions

3,356

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.

Account

Keystone Financial Group Abbott Laboratories Transaction History